Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional study

Background: About 37 million people are living with human-immunodeficiency-virus (HIV) worldwide, with 2.6 million co-infected with the hepatitis B virus (HBV). HBV infection causes 650 000 deaths annually worldwide. Botswana has a high prevalence of HIV and a growing population of patients on highl...

Full description

Bibliographic Details
Main Authors: Azhani Mandiwana, Stephane Tshitenge
Format: Article
Language:English
Published: AOSIS 2017-07-01
Series:South African Family Practice
Subjects:
Online Access:https://safpj.co.za/index.php/safpj/article/view/4716
_version_ 1818357298719883264
author Azhani Mandiwana
Stephane Tshitenge
author_facet Azhani Mandiwana
Stephane Tshitenge
author_sort Azhani Mandiwana
collection DOAJ
description Background: About 37 million people are living with human-immunodeficiency-virus (HIV) worldwide, with 2.6 million co-infected with the hepatitis B virus (HBV). HBV infection causes 650 000 deaths annually worldwide. Botswana has a high prevalence of HIV and a growing population of patients on highly active antiretroviral therapy (HAART). This study aimed to determine the prevalence of HIV–HBV co-infection amongst HAART eligible adult patients in some rural settings in Botswana. Methods: A cross-sectional study was conducted amongst HAART eligible adult patients at 15 HAART clinics in the Mahalapye, Ngami and Serowe Health Districts of Botswana, from August to October 2015. A total of 132 were recruited; of these 118 consented and were tested for HBsAg reactivity using Elisa. Results: Six (5.1%, 6/118) patients from the three rural health districts were HIV–HBV co-infected, with three in the 20–29 age group. The association between sex and HIV–HBV co-infection status was not statistically significant; p = 1.00. Conclusion: The finding of 5.1% HIV–HBV co-infection prevalence in some rural settings of Botswana was similar to results from one study conducted in a Botswana urban centre, while another previous similar study reported prevalence as being twice as high. This finding may call for prioritisation of pre-HAART HBV screening and early HAART initiation for all HIV-infected patients. (Full text of the research articles are available online at www.medpharm.tandfonline.com/ojfp) S Afr Fam Pract 2017; DOI: 10.1080/20786190.2016.1272230
first_indexed 2024-12-13T20:10:53Z
format Article
id doaj.art-40a5b0ed5dce4dd08fd3685cefcb4409
institution Directory Open Access Journal
issn 2078-6190
2078-6204
language English
last_indexed 2024-12-13T20:10:53Z
publishDate 2017-07-01
publisher AOSIS
record_format Article
series South African Family Practice
spelling doaj.art-40a5b0ed5dce4dd08fd3685cefcb44092022-12-21T23:32:55ZengAOSISSouth African Family Practice2078-61902078-62042017-07-0159310.4102/safp.v59i3.47163758Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional studyAzhani Mandiwana0Stephane Tshitenge1Botswana Defence ForceUniversity of BotswanaBackground: About 37 million people are living with human-immunodeficiency-virus (HIV) worldwide, with 2.6 million co-infected with the hepatitis B virus (HBV). HBV infection causes 650 000 deaths annually worldwide. Botswana has a high prevalence of HIV and a growing population of patients on highly active antiretroviral therapy (HAART). This study aimed to determine the prevalence of HIV–HBV co-infection amongst HAART eligible adult patients in some rural settings in Botswana. Methods: A cross-sectional study was conducted amongst HAART eligible adult patients at 15 HAART clinics in the Mahalapye, Ngami and Serowe Health Districts of Botswana, from August to October 2015. A total of 132 were recruited; of these 118 consented and were tested for HBsAg reactivity using Elisa. Results: Six (5.1%, 6/118) patients from the three rural health districts were HIV–HBV co-infected, with three in the 20–29 age group. The association between sex and HIV–HBV co-infection status was not statistically significant; p = 1.00. Conclusion: The finding of 5.1% HIV–HBV co-infection prevalence in some rural settings of Botswana was similar to results from one study conducted in a Botswana urban centre, while another previous similar study reported prevalence as being twice as high. This finding may call for prioritisation of pre-HAART HBV screening and early HAART initiation for all HIV-infected patients. (Full text of the research articles are available online at www.medpharm.tandfonline.com/ojfp) S Afr Fam Pract 2017; DOI: 10.1080/20786190.2016.1272230https://safpj.co.za/index.php/safpj/article/view/4716botswanahbsag screeninghiv–hbv co-infection prevalence
spellingShingle Azhani Mandiwana
Stephane Tshitenge
Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional study
South African Family Practice
botswana
hbsag screening
hiv–hbv co-infection prevalence
title Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional study
title_full Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional study
title_fullStr Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional study
title_full_unstemmed Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional study
title_short Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional study
title_sort prevalence of human immunodeficiency virus hepatitis b virus co infection amongst adult patients in mahalapye ngami serowe botswana a descriptive cross sectional study
topic botswana
hbsag screening
hiv–hbv co-infection prevalence
url https://safpj.co.za/index.php/safpj/article/view/4716
work_keys_str_mv AT azhanimandiwana prevalenceofhumanimmunodeficiencyvirushepatitisbviruscoinfectionamongstadultpatientsinmahalapyengamiserowebotswanaadescriptivecrosssectionalstudy
AT stephanetshitenge prevalenceofhumanimmunodeficiencyvirushepatitisbviruscoinfectionamongstadultpatientsinmahalapyengamiserowebotswanaadescriptivecrosssectionalstudy